Our analysis supports these data which shows that diabetes incidence is lower in men who develop prostate cancer in the placebo arm and inherit one of the SNPs near HNF1B. However this association is not seen in men who have Finasteride who have higher rates of type 2 diabetes and could possibly suggest a metabolic interaction between the drug and the SNP. This evidence concerns the gene HNF1B and prostate carcinoma.